Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06372925 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Intravascular Imaging Study of the Effect of Inclisiran on Plaque in Patients With Acute Myocardial Infarction

Study acronym: V-ACCELERATE
StatusActive, Not Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Enrollment closed, study ongoing Study sites: 20 to 19v12 Show 1 more changeShow less
    • Study sites: 20 to 19
  2. Enrollment target: 334 to 318v11
  3. Primary completion pushed from Jun 24, 2026 to Dec 30, 2026 Trial status changed: Active, Not Recruiting → Recruiting · Completion pushed from Jun 24, 2026 to Jan 26, 2027 · Enrollment target: 318 to 334 · 2 morev10 Show 5 more changesShow less
    • Trial status changed: Active, Not Recruiting → Recruiting
    • Completion pushed from Jun 24, 2026 to Jan 26, 2027
    • Enrollment target: 318 to 334
    • Site details revised at 20 of 20 sites
    • Study description shortened, about 2 words

    See this version in full on ClinicalTrials.gov ↗

  4. Start date: Jul 12, 2024 to Jul 9, 2024v9
  5. Trial status: Recruiting to Active, Not Recruiting Study sites: 19 to 20v8 Show 1 more changeShow less
    • Study sites: 19 to 20
Show 6 earlier versionsHide 6 earlier versions
  1. Study sites: 18 to 19v7
  2. Study sites: 1 to 18v6
  3. 3 versions Re-verified since Sep 26, 2024, no change to tracked fieldsv3-v5
  4. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 1 · Start date changed from estimate of Jul 23, 2024 to Jul 12, 2024v2 Show 2 more changesShow less
    • Study sites: 0 to 1
    • Start date changed from estimate of Jul 23, 2024 to Jul 12, 2024
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Novartis
555 trials monitored
See 31 trials at risk
This study is to evaluate the effect of Inclisiran on coronary atherosclerosis using intravascular ultrasound (IVUS) and optical coherence tomography (OCT) in patients with acute myocardial infarction and elevated low-density lipoprotein cholesterol (LDL-C).
Trial Details
NCT Number NCT06372925
Lead Sponsor Novartis Pharmaceuticals
Conditions Plaque, Atherosclerotic
Enrollment 318 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov